ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer.
about
Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study.Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel.Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models.In vitro metabolism of a triclyclic alkaloid (M445526) in human liver microsomes and hepatocytes.
P2860
ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
ZD6126 inhibits orthotopic gro ...... model of human gastric cancer.
@ast
ZD6126 inhibits orthotopic gro ...... model of human gastric cancer.
@en
type
label
ZD6126 inhibits orthotopic gro ...... model of human gastric cancer.
@ast
ZD6126 inhibits orthotopic gro ...... model of human gastric cancer.
@en
prefLabel
ZD6126 inhibits orthotopic gro ...... model of human gastric cancer.
@ast
ZD6126 inhibits orthotopic gro ...... model of human gastric cancer.
@en
P2093
P2860
P356
P1476
ZD6126 inhibits orthotopic gro ...... model of human gastric cancer
@en
P2093
M F McCarty
N Reinmuth
O Stoeltzing
P F Mansfield
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601490
P407
P577
2004-02-01T00:00:00Z